Methylated vs Cheap B-Complex — and the "B-100" Megadose Trap
Educational summary — not medical advice. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
The short answer
Two things separate a thoughtful B-complex from a marketing one, and the marketing gets both half-wrong. Form: the active folate 5-MTHF genuinely beats folic acid — about 2.3× the plasma folate, no unmetabolized folic acid (Obeid 2020) — but the parallel claim that methylcobalamin and P5P are "clinically superior" is biochemistry, not proven. Dose: "B-50"/"B-100" products push vitamin B6 to 50–100 mg, at or near the 100 mg Upper Limit tied to nerve damage — for no benefit outside deficiency. Only 3 of 11 products get both right.
Axis 1 — Form: active vs cheap (and where the evidence actually is)
"Methylated," "active," "coenzyme" B-complexes use the forms your body uses directly. The cheap forms need a conversion step first. Here's the honest breakdown of the three that matter:
| Vitamin | Cheap form | Active form | Is "active" proven better? |
|---|---|---|---|
| Folate (B9) | Folic acid | 5-MTHF / methylfolate (Metafolin, Quatrefolic) | Yes — a real PK edge. ~2.3× plasma folate, no unmetabolized folic acid (Obeid 2020; Wright 2010) |
| B12 | Cyanocobalamin | Methylcobalamin | Biochemistry only. The coenzyme form is logical, but no clinical trial shows better outcomes in people |
| B6 | Pyridoxine HCl | P5P (pyridoxal-5-phosphate) | Biochemistry only. Direct coenzyme form, but no proven clinical superiority |
The critical distinction: folate is the one form choice with real data. 5-MTHF is the circulating form, folic acid must be enzymatically converted (a limited step), and high folic-acid intakes can leave unmetabolized folic acid in the blood — 5-MTHF avoids that (Wright 2010). For B12 and B6, the "active is superior" story is a reasonable biochemical argument that trials have not confirmed, so don't pay a big premium for it.
Where the marketing overreaches A label that says "fully methylated, superior bioavailability" is right about folate and overselling B12 and B6. The genuinely defensible reason to prefer an active-form B-complex is the folate PK difference (Obeid 2020). Everything else in the "active forms absorb better" pitch is biochemistry dressed up as a clinical claim.
Axis 2 — Dose: the "B-50 / B-100" megadose trap
Here's the axis the "active forms" debate distracts from — and it's the one with a safety stake. Many B-complexes are branded "B-50" or "B-100," a loose convention that lands several B vitamins at 50 or 100 mg. For most B vitamins that's harmless excess you excrete. But it drags vitamin B6 up to 50–100 mg — and B6 is the one B vitamin with a real toxicity ceiling.
- B6 has a 100 mg/day Upper Limit. The tolerable Upper Intake Level for vitamin B6 in adults is 100 mg/day (NIH Office of Dietary Supplements / Institute of Medicine) — not a PMID, an authoritative reference value. Above it, risk rises.
- Chronic high-dose B6 causes a sensory neuropathy. The classic case series described tingling, numbness, and unsteady gait in people taking large B6 doses — a peripheral sensory neuropathy that is usually reversible on stopping (Schaumburg 1983). This is the basis for the 100 mg limit.
- There's no upside to pay for the risk. Outside treating a diagnosed deficiency, high B6 doses have no established benefit — and the homocysteine-lowering they contribute to doesn't reduce heart events (see the evidence). So a "B-100" trades a real risk for no proven reward.
Put together Because the active-forms pitch is only fully true for folate (axis 1), while the "high-potency" branding quietly pushes B6 to the 100 mg neuropathy limit (axis 2), the ideal B-complex is an active-form product with a deliberately modest B6 dose — not the biggest number on the shelf. Of the 11 products we track, 2 sit right at the 100 mg B6 Upper Limit (NOW Foods NOW Vitamin B-100 (100 Veg Capsules), Solgar B-Complex '100' (100 Veg Capsules)). Solgar even prints a neuropathy caution on its own B-100 label — the manufacturer flagging its own dose.
A note on the branding itself: "B-50" and "B-100" are a marketing convention, not a standardized spec. The number is a loose family label, not a guarantee of how much of each B vitamin — including B6 — is inside. Don't read the name; read the vitamin B6 mg line on the Supplement Facts panel.
The clean tier (active forms + a sane B6 dose)
Exactly 3 of the 11 products we track hit the cleanest combination: active forms and a B6 dose under 50 mg, comfortably below the 100 mg limit. That's the tier worth targeting — you get the real folate advantage without the megadose B6 risk. The full ranking, methylated-first and with every B6 megadose flagged, is on best B-complex.
As an Amazon Associate we earn from qualifying purchases. Ranked by form and B6 safety, never commissions.
What to actually do
- Prefer 5-MTHF over folic acid. That's the one form choice with real PK data behind it (Obeid 2020). Look for "L-5-MTHF," "methylfolate," "Metafolin," or "Quatrefolic" on the panel.
- Don't pay a premium for "active B12/B6." Methylcobalamin and P5P are fine, but their clinical superiority is unproven — it's a mild preference, not a reason to overpay.
- Read the B6 mg, not the "B-50/B-100" name. Keep B6 well under the 100 mg Upper Limit — a modest dose (say, under 25–50 mg) is plenty outside a diagnosed deficiency.
- Skip the megadose. "High-potency" B6 near 100 mg carries a real neuropathy risk (Schaumburg 1983) with no proven benefit — see the full comparison.
Frequently asked questions
Is methylfolate (5-MTHF) really better than folic acid?
For the pharmacokinetics, yes: ~2.3× the plasma folate of folic acid, with no unmetabolized folic acid (Obeid 2020; Wright 2010). It's the one B-vitamin form difference with real measured data.
Are methylcobalamin and P5P clinically superior?
Not proven. They're the direct coenzyme forms (real biochemistry), but no clinical trial shows better outcomes than cyanocobalamin or pyridoxine. Treat it as a mild preference, not a proven upgrade.
What's wrong with a "B-50" or "B-100"?
It pushes B6 to 50–100 mg, at or near the 100 mg Upper Limit tied to a sensory neuropathy (Schaumburg 1983) — with no benefit outside deficiency. Solgar prints a neuropathy caution on its own B-100.
How many products get both right?
Only 3 of 11 we track use active forms and keep B6 under 50 mg. 2 sit right at the 100 mg B6 limit. The ideal isn't the "high-potency" bottle.
Related
- B-complex dosage guide — what each B does + the B6 limit and a form & safety checker
- Best B-complex — ranked methylated-first, then by B6 dose
- Does a B-complex work? — the honest evidence on homocysteine, energy, and stress
Sources
- Obeid R, et al. "Folate supplementation and 5-MTHF pharmacokinetics: 2.3× plasma folate vs folic acid, no unmetabolized folic acid." Nutrients. 2020. PMID: 33255787
- Wright AJ, et al. "Comparison of (6S)-5-methyltetrahydrofolic acid v. folic acid: pharmacokinetics and the forms are not interchangeable." Br J Nutr. 2010. PMID: 19852872
- Schaumburg H, et al. "Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome." N Engl J Med. 1983. PMID: 6308447 (basis for the B6 neuropathy caution).
- Vitamin B6 tolerable Upper Intake Level, 100 mg/day for adults: NIH Office of Dietary Supplements / Institute of Medicine (reference value, not a PMID).
- Full product dataset: /b-complex/cost-by-brand.json (CC BY 4.0).